Dedicated to helping patients suffering with serious rare diseases
by discovering and developing novel medicines to treat their conditions
Mitochondrial disease is a devastating rare disease that affects about 75,000 people in the United States.
The Mitochondrion: Power Plant for the Cell
Our lead product candidate, R007, is a Phase-2 ready small molecule for the treatment of inherited mitochondrial disease.